IP Verse

Methods For Obtaining Muscle Derived Cells

Patent No. EP3724319 (titled "Methods For Obtaining Muscle Derived Cells") was filed by Innovacell on Dec 14, 2018. The application was issued on Apr 5, 2023.

Patent Summary

This method for obtaining skeletal muscle derived cells (SMDCs) involves four primary steps: (a) cooling a skeletal muscle tissue sample in a buffer; (b) processing and cooling the sample at 1–16°C for 2–48 hours; (c) resuspending the sample in a serum-containing medium with at least one enzyme, heating to 25–38°C for 1–20 hours, and pelleting; and (d) resuspending the pellet to produce a single-cell suspension of SMDCs. These SMDCs, which may be characterized by markers such as CD105, CD56, A2B5, Myf5, and Pax7, are intended for use in pharmaceutical compositions to improve neuro-muscular connections or treat muscle dysfunctions, specifically urinary and anal incontinence, by repairing damaged sphincters through autologous transplantation.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
OLIGSCHLAGERJan 3, 2024WITTHOFF JAEKEL STEINECKE PATENTANWALTE PARTG MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3724319

INNOVACELL
Application Number
EP18815731A
Filing Date
Dec 14, 2018
Status
Granted And Under Opposition
Mar 3, 2023
Publication Date
Apr 5, 2023
External Links
Slate, Register , Google Patents